drugset / Trial / NCT00426283
A Study of Flovent in Patients With Eosinophilic Esophagitis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to test the effects (both good and bad) of high dose swallowed fluticasone propionate (Flovent) in subjects with eosinophilic esophagitis (EoE).
Timeline
- Start
- 2007-01
- Primary completion
- 2011-12
- Completion
- 2012-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluticasone propionate | Other / unclassified | 1760 ug | Oral |